A recent study reported that an injection of a sub-toxic dose of BMAA into the cerebrospinal fluid delayed the progression of ALS in an ALS mouse model, which was suggested to have occurred due to prevention of the down-regulation of Na+/Ca2+ exchanger 3 (NCX3)42. The gene discussed is SLC8A3; the disease is amyotrophic lateral sclerosis.